Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

2(40.0%)

5Total

N/A(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04343898Completed

Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

Role: collaborator

NCT03149757Not ApplicableCompleted

Connecting Youth and Young Adults to Optimize ART Adherence: YouTHrive Efficacy Trial

Role: collaborator

NCT03805451Not ApplicableCompleted

Life Steps for PrEP for Youth

Role: collaborator

NCT02519231Phase 4Completed

Copper IUD Treatment Observation Study

Role: collaborator

NCT02668276Not ApplicableCompleted

Engaging Newly Diagnosed Men About Cancer Treatment Options

Role: collaborator

NCT00892333Completed

Large Abdominal Hernia Repair With SurgiMend 3.0

Role: collaborator

NCT01747746Phase 4Completed

Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study

Role: collaborator

All 7 trials loaded